– USA, CA – Twist Bioscience Corporation (NASDAQ: TWST) announced the appointment of Trynka Shineman Blake to its board of directors, bringing nearly three decades of experience across multiple strategic areas, including corporate governance, customer experience, digital transformation, and global marketing.
Trynka Shineman Blake will also join the audit committee.
About Trynka Shineman Blake
Trynka Shineman Blake served as CEO of Vistaprint, a Cimpress company. Before that, she held various positions of increasing responsibility at Vistaprint, including president of North America, executive vice president of global marketing, and chief customer officer. During her tenure at Vistaprint, she played a pivotal role in scaling the business from under $100 million to more than $1 billion in revenue. She aligned the organization under a customer-centric culture, led a comprehensive re-architecture of the company’s technology platform to accelerate the pace of product launches, and nurtured an innovation portfolio that expanded Vistaprint’s offerings into new markets and services.
Before Vistaprint, she held senior positions at PreVision Marketing, a boutique analytics and marketing agency.
Trynka Shineman Blake serves on the boards of several public and private companies, including Tripadvisor, Semrush, Captura, a Charlesbank company, and Steer. She previously served on the boards of Ally Financial Inc. and UBM, PLC; the Management Board of Vistaprint (Cimpress) and the Board of Trustees for the Mass Technology Leadership Council.
Trynka Shineman Blake holds a B.A. in psychology from Cornell University and an M.B.A. from Columbia Business School.
About Twist Bioscience Corporation
At Twist Bioscience, we work in the service of customers who are changing the world for the better. In fields such as medicine, agriculture, and industrial chemicals, by using our synthetic DNA tools, our customers are developing ways to better lives and the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.
Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing, and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead.
For more: https://www.twistbioscience.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.